BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20117931)

  • 1. Selection of inhibitory peptides for Aurora-A kinase from a phage-displayed library of helix-loop-helix peptides.
    Fujiwara D; Ye Z; Gouda M; Yokota K; Tsumuraya T; Fujii I
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1776-8. PubMed ID: 20117931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of a carbohydrate-binding domain with a helix-loop-helix structure.
    Matsubara T; Iida M; Tsumuraya T; Fujii I; Sato T
    Biochemistry; 2008 Jul; 47(26):6745-51. PubMed ID: 18540680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical Modification of Phage-Displayed Helix-Loop-Helix Peptides to Construct Kinase-Focused Libraries.
    Fujiwara D; Mihara K; Takayama R; Nakamura Y; Ueda M; Tsumuraya T; Fujii I
    Chembiochem; 2021 Dec; 22(24):3406-3409. PubMed ID: 34605137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage selection of peptide "microantibodies".
    Fujiwara D; Fujii I
    Curr Protoc Chem Biol; 2013; 5(3):171-94. PubMed ID: 24391082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of peptides mimicking the ligands of proteins phosphorylated by protein kinase CK2.
    Cardellini E; Felici F; Gianfranceschi GL
    Peptides; 2004 Feb; 25(2):191-7. PubMed ID: 15063000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of peptide substrate and small molecule inhibitors of testis-specific serine/threonine kinase1 (TSSK1) by the developed assays.
    Zhang L; Yan Y; Liu Z; Abliz Z; Liu G
    J Med Chem; 2009 Jul; 52(14):4419-28. PubMed ID: 19530700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of alkenyl indazoles as selective Aurora kinase inhibitors.
    Blanchard S; William AD; Lee AC; Poulsen A; Teo EL; Deng W; Tu N; Tan E; Goh KL; Ong WC; Ng CP; Goh KC; Bonday Z; Sun ET
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2443-7. PubMed ID: 20338758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid determinants of beta-hairpin conformation in erythropoeitin receptor agonist peptides derived from a phage display library.
    Skelton NJ; Russell S; de Sauvage F; Cochran AG
    J Mol Biol; 2002 Mar; 316(5):1111-25. PubMed ID: 11884148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneously synthesized peptides on continuous cellulose membranes as substrates for protein kinases.
    Toomik R; Edlund M; Ek P; Obrink B; Engström L
    Pept Res; 1996; 9(1):6-11. PubMed ID: 8727478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and conformational properties of protein fragments based on the Id family of DNA-binding and cell-differentiation inhibitors.
    Kiewitz SD; Cabrele C
    Biopolymers; 2005; 80(6):762-74. PubMed ID: 15880794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of selective aminothiazole aurora kinase inhibitors.
    Andersen CB; Wan Y; Chang JW; Riggs B; Lee C; Liu Y; Sessa F; Villa F; Kwiatkowski N; Suzuki M; Nallan L; Heald R; Musacchio A; Gray NS
    ACS Chem Biol; 2008 Mar; 3(3):180-92. PubMed ID: 18307303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification, SAR studies, and X-ray co-crystallographic analysis of a novel furanopyrimidine aurora kinase A inhibitor.
    Coumar MS; Tsai MT; Chu CY; Uang BJ; Lin WH; Chang CY; Chang TY; Leou JS; Teng CH; Wu JS; Fang MY; Chen CH; Hsu JT; Wu SY; Chao YS; Hsieh HP
    ChemMedChem; 2010 Feb; 5(2):255-67. PubMed ID: 20039358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An examination of glutamic acid in the -X chelating position of the helix-loop-helix calcium binding motif.
    Procyshyn RM; Reid RE
    Arch Biochem Biophys; 1994 Jun; 311(2):425-9. PubMed ID: 7911293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and biological evaluation of a novel aurora A kinase inhibitor.
    Sardon T; Cottin T; Xu J; Giannis A; Vernos I
    Chembiochem; 2009 Feb; 10(3):464-78. PubMed ID: 19199284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with aurora kinase inhibitors: a review.
    Boss DS; Beijnen JH; Schellens JH
    Oncologist; 2009 Aug; 14(8):780-93. PubMed ID: 19684075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioisosteric approach to the discovery of imidazo[1,2-a]pyrazines as potent Aurora kinase inhibitors.
    Meng Z; Kulkarni BA; Kerekes AD; Mandal AK; Esposite SJ; Belanger DB; Reddy PA; Basso AD; Tevar S; Gray K; Jones J; Smith EB; Doll RJ; Siddiqui MA
    Bioorg Med Chem Lett; 2011 Jan; 21(1):592-8. PubMed ID: 21075632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and development of aurora kinase inhibitors as anticancer agents.
    Pollard JR; Mortimore M
    J Med Chem; 2009 May; 52(9):2629-51. PubMed ID: 19320489
    [No Abstract]   [Full Text] [Related]  

  • 18. Selection of novel peptide mimics of the GD2 ganglioside from a constrained phage-displayed peptide library.
    Horwacik I; Czaplicki D; Talarek K; Kowalczyk A; Bolesta E; Kozbor D; Rokita H
    Int J Mol Med; 2007 May; 19(5):829-39. PubMed ID: 17390090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and conformation of an analog of the helix-loop-helix domain of the Id1 protein containing the O-acyl iso-prolyl-seryl switch motif.
    Beisswenger M; Yoshiya T; Kiso Y; Cabrele C
    J Pept Sci; 2010 Jun; 16(6):303-8. PubMed ID: 20474042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of structure in antibody cross-reactivity between peptides and folded proteins.
    Craig L; Sanschagrin PC; Rozek A; Lackie S; Kuhn LA; Scott JK
    J Mol Biol; 1998 Aug; 281(1):183-201. PubMed ID: 9680484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.